|
|
|
|
Top News
|
|
|
|
Novo Nordisk's 'surprising' patent loss opens the door to cost savings and competition
Semaglutide, the ingredient in Ozempic and Wegovy, will soon move to generic status in Canada and consultants hope this sparks plan sponsors to take a proactive approach to weight management
|
|
|
|
Why one-size-fits-all rewards no longer meet employee expectations
Personalization, data and strategic storytelling are reshaping total rewards
|
|
|
Premium
|
|
|
|
Target date funds: solving for better retirement outcomes
Sun Life Global Investments' glidepath helps sponsors meet their plan members' retirement needs
|
|
|
|
|
More News
|
|
|
|
'I'm extraordinarily optimistic because everything is so pessimistic'
Under pressure, Canada's economy still holds long-term possibilities for institutional investors, according to experts speaking at TD's Sharing of Knowledge event
|
|
|
|
Albertans strongly oppose separate pension plans, according to new survey
Only 10% agreed to withdrawing from the CPP
|
|
|
|
Quebec pension fund drops real estate brand names
Historic names vanish in $100-million revamp of strategy
|
|
|
|
CPPIB invests $720 million to support European PBSA platform expansion
Acquisition is part of the platform's plan to offer 25,000 beds across Europe by 2031
|
